Biocorrx (BICX) Expected to Announce Earnings on Monday

Biocorrx (OTCMKTS:BICX) is anticipated to release its resultson Monday, March 30th. Analysts expect Biocorrx to post earnings of ($0.06) per share and revenue of $0.22 million for the quarter.

Biocorrx Stock Performance

Shares of OTCMKTS:BICX remained flat at $0.40 during trading on Wednesday. The stock had a trading volume of 6 shares, compared to its average volume of 1,663. Biocorrx has a 1-year low of $0.20 and a 1-year high of $0.50. The firm has a market capitalization of $10.56 million, a price-to-earnings ratio of -1.25 and a beta of 0.33. The company has a 50-day moving average price of $0.34 and a 200-day moving average price of $0.36.

Biocorrx Company Profile

BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.